)
Q32 Bio (QTTB) investor relations material
Q32 Bio Registration filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Company overview and business model
Clinical-stage biotechnology company focused on therapies for alopecia areata and autoimmune diseases.
Lead candidate bempikibart is a monoclonal antibody targeting interleukin-7 receptor alpha, with Phase 2a trials completed for alopecia areata and atopic dermatitis.
Corporate restructuring in February 2025 shifted focus to bempikibart, with non-core assets sold or retained for strategic review.
Incorporated in Delaware, with a recent merger and name change in March 2024; common stock trades on Nasdaq under QTTB.
Financial performance and metrics
Designated as a smaller reporting company, eligible for scaled disclosure requirements due to market cap and revenue thresholds.
Use of proceeds and capital allocation
Net proceeds from securities sales will be used for general corporate purposes, including working capital, R&D, clinical development, commercial efforts, administrative expenses, acquisitions, and business opportunities.
- All proposals, including director elections and audit firm ratification, were approved.QTTB
AGM 202612 Jun 2026 - Q1 2026 net loss narrowed to $7.6M; cash runway into 2028 after equity raises and asset sale.QTTB
Q1 20265 May 2026 - Lead asset bempikibart delivers durable AA responses and strong safety, with pivotal data due mid-2026.QTTB
Company presentation5 May 2026 - Virtual annual meeting to vote on directors, auditor, and executive pay, with strong governance.QTTB
Proxy filing30 Apr 2026 - Election of directors, auditor ratification, and say-on-pay up for shareholder vote.QTTB
Proxy filing30 Apr 2026 - Lead asset bempikibart targets unmet needs in alopecia areata, with pivotal data due mid-year.QTTB
25th Annual Needham Virtual Healthcare Conference15 Apr 2026 - Bempikibart delivers durable, safe hair regrowth in AA, with pivotal data expected mid-2026.QTTB
Company presentation10 Mar 2026 - Q4 2025 net income surged on asset sales, with cash runway secured into late 2027.QTTB
Q4 202510 Mar 2026 - Bempikibart shows promise as a safer, durable biologic for alopecia areata, with key data due midyear.QTTB
Oppenheimer 36th Annual Healthcare Life Sciences Conference25 Feb 2026
Next Q32 Bio earnings date
Next Q32 Bio earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
Frequently asked questions
Explore our global coverage